Back
43
Day Range
$367.87
$367.90
52-Week Range
$362.28
$535.75
Volume
1
50D / 200D Avg
$383.12
/
$435.98
Prev Close
$367.90
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 57.4 | 0.4 |
| P/B | 7.4 | 2.9 |
| ROE % | 13.5 | 3.7 |
| Net Margin % | 11.7 | 3.8 |
| Rev Growth 5Y % | 16.7 | 10.0 |
| D/E | 0.4 | 0.2 |
Key Takeaways
Revenue grew 16.71% annually over 5 years — strong growth
ROE of 13.49% — decent returns on equity
Debt/Equity of 0.39 — conservative balance sheet
Negative free cash flow of -128.95M
P/E of 57.37 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 19.83%
Growth
Revenue Growth (5Y)
16.71%
Revenue (1Y)36.54%
Earnings (1Y)11.66%
FCF Growth (3Y)N/A
Quality
Return on Equity
13.49%
ROIC8.94%
Net Margin11.68%
Op. Margin15.07%
Safety
Debt / Equity
0.39
Current Ratio0.86
Interest Coverage16.99
Valuation
P/E Ratio
57.37
P/B Ratio7.39
EV/EBITDA46.53
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.54% | Revenue Growth (3Y) | 22.69% |
| Earnings Growth (1Y) | 11.66% | Earnings Growth (3Y) | 30.64% |
| Revenue Growth (5Y) | 16.71% | Earnings Growth (5Y) | 96.99% |
| Profitability | |||
| Revenue (TTM) | 748.87M | Net Income (TTM) | 87.50M |
| ROE | 13.49% | ROA | 6.58% |
| Gross Margin | 39.00% | Operating Margin | 15.07% |
| Net Margin | 11.68% | Free Cash Flow (TTM) | -128.95M |
| ROIC | 8.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.39 | Current Ratio | 0.86 |
| Interest Coverage | 16.99 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 57.37 | P/B Ratio | 7.39 |
| P/S Ratio | 6.70 | PEG Ratio | 4.28 |
| EV/EBITDA | 46.53 | Dividend Yield | 0.01% |
| Market Cap | 5.02B | Enterprise Value | 5.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 748.87M | 548.46M | 497.46M | 464.84M | 403.66M |
| Net Income | 87.50M | 78.37M | 51.28M | 23.11M | 5.81M |
| EPS (Diluted) | 6.41 | 5.74 | 3.82 | 1.82 | 0.46 |
| Gross Profit | 292.07M | 189.05M | 140.59M | 113.82M | 94.83M |
| Operating Income | 112.85M | 86.22M | 37.30M | 24.40M | 769,000.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.33B | 1.10B | 861.88M | 756.91M | 717.68M |
| Total Liabilities | 650.66M | 483.66M | 291.57M | 356.63M | 313.54M |
| Shareholders' Equity | 679.69M | 617.73M | 562.33M | 392.54M | 395.39M |
| Total Debt | 267.00M | 256.00M | 157.00M | 267.00M | 215.00M |
| Cash & Equivalents | 36.50M | 74.02M | 24.48M | 15.86M | 18.15M |
| Current Assets | 426.95M | 337.95M | 208.33M | 193.58M | 185.14M |
| Current Liabilities | 496.19M | 440.22M | 258.99M | 237.34M | 272.38M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#60 of 75
Recent Activity
Entered
Capital Heavy Grower
Mar 24, 2026